Skip to content

Usability and Acceptability Study of the P-STEP Mobile Application

Usability and Acceptability Study of the P-STEP Mobile Application

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05830318
Enrollment
178
Registered
2023-04-26
Start date
2023-08-23
Completion date
2024-03-31
Last updated
2026-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Chronic Obstructive Pulmonary Disease, Coronary Heart Disease, Heart Failure, Interstitial Lung Disease, Type 2 Diabetes

Keywords

Exercise, Pollution, Air Quality

Brief summary

Assess the usability and acceptance of the P-STEP app, through allowing participants with specific chronic conditions to pilot the app for 12-weeks.

Detailed description

Participants are asked to use mobile app for 12 weeks & complete baseline, 6 week and 12 week assessments.

Interventions

OTHERP-STEP Mobile Application

A mobile application that allows you track your walking habits while keeping you up to date with air quality information.

Sponsors

University of Leicester
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Adult ≥ 18 years * Live within the boundaries of the test site (Leicester, UK). * Diagnosed with one (or more) of the following conditions: asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), coronary heart disease (CHD), heart failure (HF), type 2 diabetes * Android smartphone which has access to the internet * Can walk outside for a minimum of 5 minutes without feeling uneasy/unsteady * Available to pilot the app for 12 weeks from August-December 2023 * Able to give informed consent to participate in the evaluation

Exclusion criteria

* English language restriction * Advised not to do exercise by a health care professional, in the last 12 months. * Access to an iOS smartphone only * Diagnosed with dementia, learning disability, mental health disorders (other than depression or anxiety), epilepsy * Receiving palliative care * Pregnant * Chest pain at rest * Unsteady when standing or walking * Current cancer patient * Part of the P-STEP User Engagement group

Design outcomes

Primary

MeasureTime frameDescription
System Usability Scale12 weeksthe System Usability Scale (SUS) at 12 weeks. The SUS a validated scale and a popular instrument for assessing perceived usability. There are 10 items in total, 5 with a positive tone and 5 with a negative tone, the response of each ranging from strongly disagree to strongly agree. The participant's scores will be transformed onto a 0-100 scale. General guidance suggests a SUS score 68 and above to be considered above average and below 68 is below average. Scores range from 0-100, a higher score indicates higher usability.

Secondary

MeasureTime frameDescription
Usability of P-STEP App12 weeksOther than the SUS, 9 usability questions relating to the specific features of the app will be asked. Participants will also be asked to provide their general feedback on the app as well as how much they used it. Individual items in the questionnaire will be summarised with percentages. Scores range from 1-5, a higher score indicates higher usability.
User Engagement Scale Short Form12 weeksThe User Engagement Scale - Short Form (UES-SF) is a reliable a valid questionnaire containing twelve items that measure user engagement categorised into; focused attention, perceived usability, aesthetic appeal, and reward. These categories can be calculated to get an average of the scores. An overall user engagement score can be calculated with UES-SF by adding together all 12 items and dividing them equally. Scores are presented on a scale 1-5. The items can be averaged into 4 categories or averaged for an overall score. Scores range from 0-60, a higher score indicates higher user engagement.
SF-12 Health Questionnaire12 weeksThe short form 12 item (SF-12v2) health survey measures functional health and well-being from the participant's perspective. It assesses eight domains; physical functioning, physical role, pain, general health, vitality, social functioning, social role, mental health. Each domain contributes to two summary scores; physical component summary (PCS) and mental component summary (MCS). SF-12v2 responses will be scored and interpreted using the SF-12v2 user guide. The 8 domains will generate two summary scores; physical component score (PCS) and mental component score (MCS). Scores for the PCS and MCS range from 0-100, a higher score indicates a higher quality of life.
Recent Physical Activity Questionnaire12 weeksThe RPAQ is designed to find out about a participant's physical activity in their everyday life. The RPAQ will be scored and interpreted using the scoring guidelines published by the Authors. All activities are categorised with respect to their intensity, on a scale of sedentary (\<1.5), light (1.5-\<3), moderate (3-6) and vigorous (\>6). Each activity is scored by hours a day multiplied by the intensity of the activity. A higher RPAQ score indicates higher levels of physical activity.
Feasibility Outcome - Interest2 monthsPercentage of those potentially eligible who register their interest.
Feasibility Outcome - Enrolment2 monthsPercentage of participants that register interest enrol on the study.
Feasibility Outcome - App Administration3 monthsPercentage that successfully download the app.
Feasibility Outcome - App Acceptability3 monthsPercentage of participants who enrol and complete the 12-week study
Feasibility Outcome - Acceptability of the Outcome Measures3 monthsCompletion levels of questionnaire
All Cause Mortality3 monthsDescription of all cause mortality at 3 months
Cardiovascular Events3 monthsDescription of cardiovascular events at 3 months

Countries

United Kingdom

Participant flow

Recruitment details

We recruited from a pre-existing cohort study based in Leicester, United Kingdom. Participants were recruited from the EXCEED cohort study(41). The EXCEED study (REC ref 13/EM/0226) is a longitudinal population-based cohort study that facilitates the investigation of genetic, environmental and lifestyle-related determinants of a broad range of diseases and multiple long-term conditions

Pre-assignment details

This was a single arm pilot study and therefore all participants enrolled received the intervention.

Baseline characteristics

Characteristic
Age, Continuous66.25 years
STANDARD_DEVIATION 8
English first language (YES)
No
4 Participants
English first language (YES)
Not reported
40 Participants
English first language (YES)
Yes
89 Participants
Has previously attended exercise rehab program (YES)
No
69 Participants
Has previously attended exercise rehab program (YES)
Not reported
61 Participants
Has previously attended exercise rehab program (YES)
Yes
3 Participants
Long term condition(s)
Asthma
18 Participants
Long term condition(s)
COPD
4 Participants
Long term condition(s)
Heart disease
2 Participants
Long term condition(s)
Heart failure
1 Participants
Long term condition(s)
None reported
95 Participants
Long term condition(s)
Type 2 Diabetes
13 Participants
Race/Ethnicity, Customized
Asian/Asian British
6 Participants
Race/Ethnicity, Customized
Black/African/Caribbean/Black British
3 Participants
Race/Ethnicity, Customized
Missing
40 Participants
Race/Ethnicity, Customized
Mixed/Multiple ethnic groups
1 Participants
Race/Ethnicity, Customized
White
83 Participants
Sex: Female, Male
Female
59 Participants
Sex: Female, Male
Male
74 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 93
other
Total, other adverse events
32 / 93
serious
Total, serious adverse events
0 / 93

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 2, 2026